Why the study?
To validate previously proposed combined biomarkers developed to assess the likelihood of presence and severity of coronary artery atherosclerosis in an independent cohort.
Do combined non-invasive biomarkers predict the presence and severity of coronary atherosclerosis in hospitalized patients?
Do combined non-invasive biomarkers predict the presence and severity of coronary atherosclerosis in hospitalized patients?
Combined non-invasive biomarkers demonstrate high specificity for predicting the presence and severity of coronary atherosclerosis, potentially helping to avoid unnecessary coronary angiography.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Metelskaya et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: